TABLE 1.
Clinical and pathological characteristics of BCa patients between different urinary diversion after PSM
| Characteristic | Urinary diversion, % of patients | Chi‐square or Z | P value | |
|---|---|---|---|---|
| Ileal conduit (n = 409) | Orthotopic neobladder (n = 409) | |||
| Age, median (IQR) | 63 (56‐69) | 63 (55‐69) | −0.789 | .430 |
| Gender | 0.440 | .507 | ||
| Male | 97.8 | 97.1 | ||
| Female | 2.2 | 2.9 | ||
| Race | 7.585 | .108 | ||
| White | 90.2 | 89.7 | ||
| Black | 5.6 | 2.9 | ||
| AI | 0.5 | 0.5 | ||
| API | 3.4 | 6.6 | ||
| Unknown | 0.2 | 0.2 | ||
| Marital status | 3.743 | .154 | ||
| Married | 73.1 | 73.3 | ||
| No | 26.7 | 25.2 | ||
| Unknown | 0.2 | 1.5 | ||
| Primary tumor site | 11.331 | .254 | ||
| Trigone of bladder | 6.8 | 3.9 | ||
| Dome of bladder | 5.4 | 3.7 | ||
| Lateral wall of bladder | 17.1 | 17.1 | ||
| Anterior wall of bladder | 1.2 | 2.4 | ||
| Posterior wall of bladder | 7.3 | 7.8 | ||
| Bladder neck | 1.7 | 3.7 | ||
| Ureteric orifice | 1.2 | 1.5 | ||
| Urachus | 0.0 | 0.5 | ||
| Overlapping lesion of bladder | 20.0 | 20.0 | ||
| Bladder, NOS | 39.1 | 39.4 | ||
| Histology | 1.580 | .454 | ||
| Transitional cell carcinoma | 94.4 | 92.2 | ||
| Squamous cell carcinoma | 2.0 | 2.7 | ||
| Other types | 3.7 | 5.1 | ||
| Pathological T stage | 0.168 | .997 | ||
| T0‐Tis‐Ta‐T1 | 15.2 | 14.4 | ||
| T2 | 44.7 | 45.2 | ||
| T3 | 27.6 | 28.4 | ||
| T4 | 11.5 | 11.0 | ||
| Tx/NA | 1.0 | 1.0 | ||
| Pathological N stage | 3.525 | .317 | ||
| N0 | 81.2 | 79.0 | ||
| N1 | 11.0 | 9.5 | ||
| N2 | 6.6 | 10.0 | ||
| N3 | 0.0 | 0.0 | ||
| Nx/NA | 1.2 | 1.5 | ||
| Pathological M stage | 4.328 | .115 | ||
| M0 | 96.6 | 94.6 | ||
| M1 | 2.0 | 4.4 | ||
| Mx/NA | 1.5 | 1.0 | ||
| Grade | 4.916 | .296 | ||
| I | 0.7 | 0.7 | ||
| II | 4.6 | 4.2 | ||
| III | 26.9 | 34.0 | ||
| IV | 63.1 | 57.2 | ||
| Unknown | 4.6 | 3.9 | ||
| Lymphadenectomy | 2.687 | .261 | ||
| No | 2.7 | 2.7 | ||
| Yes | 96.1 | 97.1 | ||
| Others | 1.2 | 0.2 | ||
| Adjuvant radiation | 2.020 | .155 | ||
| No | 99.5 | 98.5 | ||
| Yes | 0.5 | 1.5 | ||
| Adjuvant chemotherapy | 0.127 | .721 | ||
| No | 60.6 | 59.4 | ||
| Yes | 39.4 | 40.6 | ||
Abbreviations: AI, American Indian/Alaskan Native; API, Asian/Pacific Islander; BCa, bladder cancer; IQR, interquartile range; NA, not available; NOS, not otherwise specified; PSM, propensity score matching.